Zevra Therapeutics reported quarterly earnings of 19 cents per share which beat the analyst consensus estimate of 5 cents per share. The company reported quarterly sales of $34.125 million which beat the analyst consensus estimate of $28.051 million.
Zevra Therapeutics shares jumped 17.2% to $10.70 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
Losers
Photo via Shutterstock
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.

